What Is Healthspan? Longevity vs Lifespan, Explained

• Lifespan counts years; healthspan counts years spent free of disabling disease.
• The average global gap between them reached 9.6 years, according to the 2024 JAMA Network Open analysis of WHO data.
• Life expectancy is a population average, not a prediction for any single person.
• Genetics explains a minority of the variation in how long people live, and lifestyle and environment carry the rest.
• Biological age can be estimated through several tests, none of which is a comprehensive verdict on its own.
• Aegis Capital invests in early-stage HealthTech & Longevity companies working on earlier diagnosis and treatment of age-related disease.

Longevity vs life span: what each term measures

Longevity vs life span is a comparison of two different questions. Lifespan asks how many years a person lives, while longevity in its modern usage asks how many of those years are worth having. The first is a count, the second is a description of condition.

Vitality sits alongside both and answers the question of what state a person is in: whether they can climb stairs, hold a conversation, cook a meal and get through a day without assistance. High vitality does contribute to a longer life, which is why the two measures usually move together, but neither one predicts the other reliably.

What is lifespan and how is it measured?

Lifespan is the number of years between birth and death, measured chronologically and without reference to health status. Maximum lifespan for humans stands at 122 years, the age reached by Jeanne Calment, and no verified case has come close since.

Life expectancy is an average, not a personal forecast

Life expectancy is a different figure. It gives the average number of years a person can expect to live if current mortality rates hold, which makes it a snapshot of population conditions rather than a forecast. It says nothing about any individual, for example a 60-year-old with no cardiovascular risk factors, whose realistic outlook differs sharply from the population mean. An American born in 1900 could expect to live around 47 years; the CDC reported life expectancy of 78.4 years for 2023 and 79 years for 2024, and the difference reflects sanitation, antibiotics and cardiology far more than any change in human biology.

Lifespan vs healthspan: quantity and quality

Healthspan is the period of life spent without chronic disease that limits daily functioning. Gerontologists usually assess it against three conditions:

• Absence of chronic disease that restricts everyday activity.
• Physical capacity sufficient to live independently.
• Cognitive function preserved at a level that supports decision-making.

Healthspan is harder to express as one number, which is why health-adjusted life expectancy is used as its statistical proxy. In the WHO data analyzed in 2024, mean health-adjusted life expectancy across member states stood at 63.3 years against a mean lifespan of 72.5 years.

The gap between healthy years and total years

The gap between the two figures is where the whole discussion sits. Roughly a decade at the end of an average life is spent managing disease, and that decade is expensive for health systems and exhausting for families. The pattern also has a shape: function declines slowly for years, then falls sharply, and the final stage often involves dependence on other people until the end of life.

Compression of morbidity is the alternative. Instead of extending the declining phase, the aim is to push its start closer to the end of life, so that the years of illness get shorter rather than the years of survival getting longer. That is the practical goal of longevity medicine, and it is measurable.

Which factors shape your health as you age?

Genetics sets a range rather than a destination. Twin and cohort studies attribute somewhere between 10% and 30% of the variation in lifespan to inherited factors, which leaves the majority to behavior, environment and access to medical care. Four disease groups account for most of the lost healthspan:

• Cardiovascular disease, which drives disability after stroke and heart failure.
• Neurodegenerative disease, which removes cognitive independence.
• Metabolic disease, where type 2 diabetes and excess visceral fat accelerate damage across organ systems.
• Cancer, which shortens both healthspan and lifespan.

Great differences in outcome follow from the same diagnosis depending on when it is caught, including in age related conditions that progress silently for years. Early detection matters more here than in almost any other area of medicine, because reversing organ damage is rarely possible once it becomes symptomatic.

Senescent cells and the biology of aging

Senescent cells stop dividing but do not die, and they accumulate with age while secreting inflammatory signals that damage surrounding tissue. This mechanism is one of the recognized hallmarks of aging, alongside genomic instability, telomere shortening and mitochondrial dysfunction.

Did you know: clearing senescent cells extended healthy life in mouse studies, which is why senolytic compounds moved into early human trials. No senolytic has regulatory approval for an aging indication, however, and no regulator currently recognizes aging itself as a disease, so any product sold today on that promise is running ahead of the evidence.

Measuring biological age: health and function tests

Biological age estimates how worn the organism is compared with the calendar. Several tests are available, and each measures something different:

• Epigenetic clocks read DNA methylation patterns to estimate cellular aging.
• Cardiorespiratory fitness testing measures VO2 max, one of the strongest single predictors of all-cause mortality.
• Body composition analysis separates muscle, fat and bone density, which changes how a given body weight should be interpreted.

None of these is a comprehensive picture on its own, and results vary between laboratories and between clocks. Their value lies in repetition: a measurement taken today and updated in two years shows a direction, which a single number cannot.

Four habits linked to a healthier life

The evidence for extending healthspan converges on a short list, and none of it is exotic. People who follow these four habits consistently show lower disease incidence and greater functional capacity in later decades:

• Regular exercise, combining aerobic work and resistance training. Physical activity guidelines written for adults by the WHO and updated in 2020 set 150 to 300 minutes of moderate activity per week, and cohort studies associate meeting them with a 22% to 31% lower risk of death from any cause.
• Diet built around whole foods, with protein sufficient to maintain muscle mass after 50.
• Sleep of adequate length and regularity, since sleep drives clearance processes in the brain and recovery elsewhere.
• Managing chronic stress, which is a physiological variable rather than a mood, and one that affects blood pressure, glucose and immune function.

Tip: measure one thing before you change anything. A baseline for grip strength, VO2 max or resting heart rate tells you whether what you are doing works, and today most of these can be checked without specialist equipment.

How HealthTech extends healthspan through earlier detection

Technology helping people age better works mostly at the front end, by finding disease before it becomes symptomatic. Imaging and algorithmic analysis detect structural change earlier than a physical examination does, and continuous monitoring picks up deterioration between appointments.

Example: the Aegis Capital portfolio includes Inoko Vision, developing a non-invasive optical device that reads eye movement as a biomarker of neurological state for early screening of neurodegenerative disease, and Approxima, developing a transcatheter system for tricuspid valve regurgitation, a condition of the aging heart that most patients never have treated. Both address the same problem from different directions: intervening while intervention still changes the outcome.

VC funding for longevity medicine

Building diagnostic hardware or a therapeutic device takes years of clinical work before the first sale, and that timeline is why the sector depends on investors who can price a regulatory path. Capital at the pre-seed and seed stage funds trials, quality systems and certification, all of which precede revenue.

Aegis Capital invests in early-stage HealthTech & Longevity startups in Central and Eastern Europe, with a fund capitalization of PLN 80 million, an initial ticket of up to PLN 3 million and total funding of up to PLN 8 million per company across follow-on rounds. Diagnostics, nutritech, digital therapy, AI in health and human improvement are the areas where the fund works, and each of them touches the gap this article describes.

Frequently asked questions

What is the difference between lifespan and healthspan?

Lifespan is the total number of years lived. Healthspan is the portion of those years spent without disease that limits daily functioning. A person can have a long lifespan and a short healthspan if the final decade is spent dependent on care.

Can healthspan be extended?

Yes, and the evidence supports lifestyle factors and early treatment of disease rather than supplements. No approved medical intervention currently targets aging itself, so extending healthspan today means addressing the conditions that shorten it.

How long can a human live?

The verified record is 122 years. Estimates of the biological ceiling for humans cluster between 120 and 150 years, but they are models, not observations, and no intervention has moved a person past the record.

Is biological age a real medical measure?

It is a research measure used increasingly in clinical practice, not a diagnosis. Different tests give different answers for the same person, so the result should be read as an indicator to follow over time rather than a verdict.

Why do women live longer but not healthier?

The same 2024 analysis found the healthspan-lifespan gap 2.4 years wider in women than in men, linked to a heavier burden of noncommunicable disease. Women live more years in total and spend more of them managing chronic conditions, which is one reason research on sex differences in aging keeps expanding.

‍